Kantonsspital St.Gallen


Annika Eckhold, Claudia Krieger Grübel, Stephan Brand & Marius König

abstract A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate
the Long-Term Efficacy and Safety of Mirikizumab in Patients with Crohn's Disease
type of project clinical studies
status ongoing - recruiting phase
start of project 2022
end of project 2024
study design Open Label
responsible person Prof. Dr. Stephan Brand